Abstract
Matrix metalloproteinases (MMPs) are a growing family of zinc-dependent endopeptidases that are capable of degrading various components of the extracellular matrix. These enzymes have been implicated in a variety of physiological and pathological conditions including embryogenesis and tumour invasion. The synthesis of many MMPs is thought to be regulated by growth factors, cytokines and hormones. In this study, we investigated the effects of five exogenous growth factors known to be expressed by gliomas [epidermal growth factor (EGF), basic growth factor (bFGF), transforming growth factor beta (TGF-β1,2) and vascular endothelial growth factor (VEGF)] on MMP-2 and MMP-9 expression in an ependymoma, two grade III astrocytomas, a grade III oligoastrocytoma and a benign meningioma. Zymogram analysis revealed that the effects of the growth factors depended upon the cell lines used in the study. Growth factors generally up-regulated MMP-2 and MMP-9 expression in the gliomas but were least effective in the meningioma; the effect being most prominent with TGF-β1 and TGF-β2 in all the cell lines. It is hypothesized that paracrine growth factor interplay may be crucial in the regulation of MMP expression by glioma invasion of the normal brain. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Engebraaten O, Bjerkvig R, Pedersen PH and Laerum OD (1993) Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain tumour biopsies in vitro. Int J Cancer 53: 209–214
Finn PE, Bjerkvig R and Pilkington GJ (1997) The role of growth factors in the malignant and invasive progression of intrinsic brain tumours. Anticancer Res 17: 4163–4172
Heldin C-H and Westermark B (1989) Growth factors as transforming proteins. Eur J Biochem 184: 487–496
Heussen C and Dowdle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodocyl sulfate and copolymerized substrates. Anal Biochem 102: 196–202
Kleihues P, Burger C and Scheithauer BW (1993) Histological typing of tumours of the central nervous system. In: WHO Classification, 2nd edn. Springer Verlag: Berlin
Koochekpour S, Merzak A and Pilkington GJ (1995) Growth factors and gangliosides stimulate laminin production by human glioma cells in vitro. Neurosci Lett 186: 53–56
Laerum OD (1998) The role of growth factors and oncogenes in tumour cell invasion. Brain Tumour Invasion: Biological, Clinical and Therapeutic Considerations, Mikkelsen, Bjerkvig R, Laerum OD, Rosenblum (eds), pp. 323–341
Lamoreaux WJ, Fitzgerald MEC, Reiner A, Hasty KA and Charles ST (1998) Vascular endothelial growth factor increases release of gelatinase A and decrease release of tissue inhibitors of metalloproteinases by microvascular endothelial cells in vitro. Microvascular Res 55: 29–42
Liotta LA (1986) Tumor invasion and metastases: role of the extracellular matrix (Rhodes Memorial Award Lecture). Cancer Res 46: 1–7
Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD and Laerum OD (1990) Effect of epidermal growth factor on glioma cell growth, migration and invasion in vitro. Cancer Res 50: 6039–6044
Lund-Johansen M, Forsberg K, Bjerkvig R and Laerum OD (1992) Effects of growth factors on human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropath 84: 190–197
McDougall JR and Matrisian LM (1995) Contribution of tumour and stromal matrix metalloproteinases to tumour progression, invasion and metastasis. Cancer and Metastas Rev 14: 351–362
Maidment SL, Merzak A, Koochekpour S, Rooprai HK, Rucklidge GJ and Pilkington GJ (1996) The effects of exogenous gangliosides on matrix metalloproteinase secretion by human glioma cells in vitro. Eur J Cancer 32: 868–871
Merzak A, McCrea S, Koochekpour S and Pilkington GJ (1994) Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta-1. Br J Cancer 70: 199–203
Merzak A, Koochekpour S, Dkhissi F, Raynal S, Lawrence D and Pilkington GJ (1995) Synergism between growth factors in the control of glioma cell proliferation, migration and invasion in vitro. Int J Oncol 6: 1079–1085
Nakano A, Tani E, Miyazaki K, Furuyama J and Matsumoto T (1993) Expression of matrilysin and stromelysin in human glioma cells. Biochem Res Commun 192: 999–1003
Nicolson GL, Nakajima M, Herrmann JL, Menter DG, Cavanaugh PG, Park SJ and Marchetti D (1994) Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors. J Neuro-Oncol 18: 139–149
Overall CM, Wrana JL and Sodek J (1991) Transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor β-1 in human fibroblasts. J Biol Chem 226: 14064–14071
Pedersen P-H, Ness GO, Engebraaten O, Bjerkvig R, Lillehaug JR and Laerum OD (1994) Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-α, bFGF, IL-2] on glioma spheriod growth, migration and invasion. Int J Cancer 56: 255–261
Pilkington GJ, Dunan JR, Rogers JP, Clarke TM and Knott JCA (1993) Growth factor modulation of surface ganglioside expression in cloned neoplastic glia. Neurosci Lett 149: 1–5
Rao JS, Steck PA, Tofilon P, Boyd D, Ali-Osmon F, Stetler-Stevenson WG, Liotta LA and Sawaya R (1994) Role of plasminogen activator and 92-kDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neuro-Oncol 18: 129–138
Reubi JC, Horisberger U, Lang W, Koper JW, Braakman R and Lamberts SW (1989) Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors. Am J Pathol 134: 337–344
Romanic AM and Madri JA (1994) Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol 4: 145–156
Rooprai HK and McCormick D (1997) Proteases and their inhibitors in human brain tumours: a review. Anticancer Res 17: 4152–4162
Rooprai HK, Van Meter T, Rucklidge GJ, Hudson L, Everall IP and Pilkington GJ (1998) Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Int J Oncol 13: 1153–1157
Rossi M, Rooprai HK, Maidment SL, Rucklidge GJ and Pilkington GJ (1996) The influence of sequential, in vitro passage on secretion of matrix metalloproteinases by human brain tumour cells. Anticancer Res 16: 121–128
Rucklidge GJ, Lund-Johansen M, Milne G and Bjerkvig R (1990) Isolation and characterization of a metalloproteinase secreted by rat glioma cells in serum-free culture. Biochem Biophys Res Commun 172: 544–550
Russell DS and Rubenstein LJ (1989). Pathology of Tumours of the Nervous System, 5th edn, pp. 83–289, Williams & Wilkins: Baltimore
Salo T, Lyons JG, Rahematulla F, Birkendal-Hansen H and Larjava H (1991) Transforming growth factor β-1 upregulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 226: 11436–11441
Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT and Liotta LA (1990) Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumour cell lines and human tumour tissues. J Biol Chem 265: 13933–13938
Tamaki M, McDonald W and Del Maestro RF (1998) The importance of cell density in the interpretation of growth factor effects on collagenase IV activity release and extracellular matrix production from C6 astrocytoma cells. J Neuro-Oncol 39: 205–216
Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB 5: 2145–2154
Yamada KM (1983) Cell surface interactions with extracellular material. Ann Rev Biochem 52: 761–799
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Rooprai, H., Rucklidge, G., Panou, C. et al. The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. Br J Cancer 82, 52–55 (2000). https://doi.org/10.1054/bjoc.1999.0876
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.0876
Keywords
This article is cited by
-
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Signal Transduction and Targeted Therapy (2023)
-
The biology of ependymomas and emerging novel therapies
Nature Reviews Cancer (2022)
-
Selective suppression of the JNK-MMP2/9 signal pathway by tetramethylpyrazine attenuates neuropathic pain in rats
Journal of Neuroinflammation (2017)
-
Zinc and zinc-containing biomolecules in childhood brain tumors
Journal of Molecular Medicine (2016)
-
Deficiency of the protein-tyrosine phosphatase DEP-1/PTPRJ promotes matrix metalloproteinase-9 expression in meningioma cells
Journal of Neuro-Oncology (2015)